Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126238971 | 12623897 | 1 | I | 20160724 | 20160804 | 20160804 | EXP | TR-ELI_LILLY_AND_COMPANY-TR201608001098 | ELI LILLY AND CO | 44.00 | YR | F | Y | 0.00000 | 20160804 | OT | TR | TR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126238971 | 12623897 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 30 MG, QD | Y | U | 21427 | 30 | MG | CAPSULE | QD | ||||
126238971 | 12623897 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | Y | U | 21427 | 60 | MG | CAPSULE | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126238971 | 12623897 | 1 | Major depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126238971 | 12623897 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126238971 | 12623897 | Headache | |
126238971 | 12623897 | Optic atrophy | |
126238971 | 12623897 | Optic neuritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |